A new maximum color contrast sensitivity test for detecting early changes of visual function in age-related macular degeneration

Medicina (Kaunas). 2014;50(5):281-6. doi: 10.1016/j.medici.2014.10.008. Epub 2014 Nov 1.

Abstract

Background and objective: To determine the association between age-related macular degeneration (AMD) and color perception established by the Farnsworth-Munsell 100 hue (F-M 100) and maximum color contrast sensitivity (MCCS) tests.

Materials and methods: We performed a case-control study, which comprised of 100 patients with AMD and 100 healthy controls. To test visual acuity (VA), a typical Snellen chart was used. The computerized F-M 100 and MCCS programs were used for color discrimination.

Results: The results of VA, and the F-M 100 and MCCS tests in the healthy controls were statistically significantly better than in the patients with AMD (1.0 vs. 0.82±0.16, P=0.005; 87.39±24.11 vs. 185.39±74.43, P=0.005; 1.33±1.17 vs. 1.96±0.46, P=0.005, respectively). When VA was 1.0 in patients with AMD, the total error scores of the F-M 100 test and MCCS test compared with healthy persons were even worse (166.09±66.57 vs. 87.39±24.11, P=0.002; 1.67±0.92 vs. 1.33±1.17, P=0.001, respectively). Analysis of the results of patients with AMD compared to healthy controls showed the highest error score in the blue color range.

Conclusions: The results of the color contrast sensitivity test decreased by half in patients with AMD compared with ophthalmologically healthy patients when they performed the F-M 100 test and by one and half when they performed a MCCS test in the blue color range.

Keywords: Age-related macular degeneration; Color vision; Farnsworth–Munsell 100 hue test; Visual acuity.

MeSH terms

  • Aged
  • Case-Control Studies
  • Color Perception*
  • Contrast Sensitivity*
  • Female
  • Humans
  • Macular Degeneration / diagnosis*
  • Macular Degeneration / physiopathology
  • Male
  • Middle Aged